Actinium Pharmaceuticals, Inc. (NYSE MKT: ATNM) and Memorial Sloan Kettering Cancer Center announced that they have entered into a definitive agreement providing for certain liquidity matters and sale restrictions in respect of the shares of Actinium stock that MSK received as a charitable donation and intends to divest pursuant to MSK policies. MSK and Actinium remain committed to their research relationship as evidenced by ongoing collaborations, clinical research contract and involvement in the development of both Actimab-A and Iomab-B via the participation of MSK physician-scientists on Actinium’s Clinical and Scientific Advisory Boards.
Actinium Pharmaceuticals, Inc. (NYSEMKT:ATNM) belongs to Healthcare sector. Its weekly performance is -8.65%. On last trading day company shares ended up at $2.85. Actinium Pharmaceuticals, Inc. (NYSEMKT:ATNM) distance from 50-day simple moving average (SMA50) is 25.05%.
Karyopharm Therapeutics Inc. (NASDAQ:KPTI), a clinical-stage pharmaceutical company, announced that Michael G. Kauffmann, MD, PhD, Chief Executive Officer of Karyopharm, is scheduled to present at the upcoming J.P. Morgan 34th Annual Healthcare Conference in San Francisco on Wednesday, January 13, 2016 at 8:30 a.m. PT.
Karyopharm Therapeutics, Inc. (NASDAQ:KPTI) shares fell -15.40% in last trading session and ended the day at $11.59. KPTI return on assets is -45.50%. Karyopharm Therapeutics, Inc. (NASDAQ:KPTI) quarterly performance is 1.31%.
On 06 January, Fomento Economico Mexicano SAB (ADR) (NYSE:FMX) shares fell -1.95% and was closed at $89.11. FMX EPS growth in last 5 year was 11.40%. Fomento Economico Mexicano SAB (ADR) (NYSE:FMX) year to date (YTD) performance is -3.51%.
On 21st December, Hansen Medical, Inc. (NASDAQ: HNSN), announced it has completed a transaction for a Sensei X Robotic System at Maastricht University Medical Center in Maastricht, Netherlands. The commercial process was completed through a joint commercial effort with Medtronic International Trading SARL, a key partner with Maastricht University Medical Center, a prominent European therapeutic and training center.
Hansen Medical, Inc. (NASDAQ:HNSN) ended the last trading day at $2.23. Company weekly volatility is calculated as 4.14% and price to cash ratio as 1.39. Hansen Medical, Inc. (NASDAQ:HNSN) showed a weekly performance of -8.23%.
Levi & Korsinsky, LLP announces that it has commenced an investigation of JinkoSolar Holding Co., Ltd. (NYSE:JKS) concerning possible violations of federal securities laws by certain officers and directors.
JinkoSolar Holding Co., Ltd. (NYSE:JKS) shares fell -1.00% in last trading session and ended the day at $25.76. JKS Gross Margin is 21.30% and its return on assets is 2.60%. JinkoSolar Holding Co., Ltd. (NYSE:JKS) quarterly performance is 2.47%.